Depression and Anxiety Trial, Recruiting NCT03813290 Sponsor: National Healthcare Group, Singapore Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT03813290
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 13 to 18 years old (inclusive)
  • People who can read and write in English
  • People who have been newly diagnosed with Generalised Anxiety Disorder (a current episode), confirmed through a specific computerised diagnostic interview
  • People who are taking medication, provided the dose has been stable and unchanged for at least the past 8 weeks
  • People whose parent or guardian has given consent for them to participate

Who may not be able to join:

  • People who have been diagnosed with an anxiety disorder that is caused by a medication, substance, or other medical condition; obsessive compulsive disorder; bipolar disorder; any psychotic disorder (at any point in their lifetime); intellectual disability (an IQ below 70); autism spectrum disorder; or attention-deficit/hyperactivity disorder
  • People who have had a problem with substance or drug use in the last 3 months
  • People who have a neurological condition, such as epilepsy or a history of stroke
  • People who have metal in their skull, skull defects, or skin problems on the scalp (such as cuts, sores, or rashes) in the areas where electrodes would be placed
  • People who have irregular heart rhythms or other heart problems
  • People who have severe vision or hearing impairment
  • People who have previously taken part in mindfulness-based therapy programs, such as Mindfulness-Based Stress Reduction (MBSR) or Mindfulness-Based Cognitive Therapy (MBCT)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lim Choon Guan, Institute of Mental Health, Singapore

Phone: +65 6435 3969

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Healthcare Group, Singapore
Registry
ClinicalTrials.gov
Start date
8 December 2020
Est. completion
1 January 2026

Where this trial is recruiting

🇸🇬 Singapore

Primary endpoints

Usability Questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov